11.07.2015 Views

Convened under the auspicious of esteemed endorsers - ISTA

Convened under the auspicious of esteemed endorsers - ISTA

Convened under the auspicious of esteemed endorsers - ISTA

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Methods: Eighteen knees (18 patients) with methicillin-resistant Staphylococcus aureus weretreated between January 2001 and January 2007 with one-stage revision protocol that includeddébridement, uncemented revision <strong>of</strong> total knee components, and intraarticular infusion <strong>of</strong> 500mg vancomycin via Hickman ca<strong>the</strong>ter once or twice daily for 6 weeks. (Figure 1) Nointravenous antibiotics were used after <strong>the</strong> first 24 hours. Serum vancomycin levels weremonitored to maintain levels between 3 and 10 µg/mL. The mean serum vancomycin peakconcentration was 6 ± 2 µg/mL and <strong>the</strong> mean serum vancomycin trough concentration was 3 ± 1µg/mL at 2 weeks postoperative.Results: Knee synovial fluid peak and trough vancomycin levels were measured in two knees.Synovial fluid peak concentrations were 10,233 µg/mL and 20,167 µg/mL and troughconcentrations were 724 µg/mL and 543µg/mL, respectively. Minimum followup was 27months (range, 27-75 months). Mean followup was 62 months, (range, 27–96 months). At 2-year followup, mean Knee Society score was 83 ± 9. No radiographic evidence <strong>of</strong> implantmigration has occurred. One knee became reinfected with methicillin-resistant Staphylococcusaureus and was reoperated at 5 months. A necrotic bone segment was found, <strong>the</strong> knee wasdebrided and revised, and <strong>the</strong> antibiotic infusion protocol was readministered. The kneeremained free <strong>of</strong> infection at 42 months postoperatively.Conclusions: One-stage revision with uncemented components and 6 weeks intraarticularvancomycin administration safely and effectively treated MRSA-infected TKA with noapparent complications.FiguresThursday, October 7, 2010, 10:20-11:00Session A3: Bearing Mobility IssuesRoughness and Surface Polarity <strong>of</strong> Retrieved Zirconia Femoral Heads*Marcel Roy - Missouri Bone and Joint Research Foundation - St. Louis, USALeo Whiteside - Missouri Bone and Joint Research Foundation - St. Louis, USATariq Nayfeh - Johns Hopkins University College <strong>of</strong> Medicine - Baltimore, USABrian Katerberg - Signal Medical Corp - St. Louis, USA*Email: mroy@mobojo.orgIntroduction: Recent clinical studies found no apparent reduction in wear using yttriastabilizedzirconia (Y-TZP) instead <strong>of</strong> cobalt chromium alloy femoral heads bearing againstcross-linked UHMWPE. The purpose <strong>of</strong> this study was to compare <strong>the</strong> surface topography <strong>of</strong>retrieved Y-TZP and magnesia-stabilized zirconia (Mg-PSZ) femoral heads and evaluate <strong>the</strong>influence <strong>of</strong> time in vivo. The increase in average roughness (Ra, Sa) <strong>of</strong> Y-TZP due to phasetransformation in vivo is well documented, while Mg-PSZ does not roughen or <strong>under</strong>go phasetransformation in vivo. However, <strong>the</strong> effects <strong>of</strong> phase transformation on <strong>the</strong> polarity (skewness,Ssk) <strong>of</strong> <strong>the</strong> surface <strong>of</strong> retrieved ZrO 2 heads has not been reported. We hypo<strong>the</strong>sized that phasefile:///E|/<strong>ISTA</strong>2010-Abstracts.htm[12/7/2011 3:15:47 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!